UNSPSC 51112204: Ifosfamide/mesna

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AN100. This VA Drug Class (AN100) classifies this compound as belonging to the group ANTINEOPLASTICS, ALKYLATING AGENTS.

UNSPSC 51112204 Ifosfamide/mesna, a Commodity code, describes a chemotherapy drug combination state and local public bodies procure for hospital and healthcare system oncology programs. Ifosfamide is a nitrogen mustard alkylating agent used in cancer treatment, typically paired with mesna as a protective agent to mitigate urinary toxicity. State and local health departments, public hospital systems, county medical centers, and integrated healthcare networks purchase this pharmaceutical under the code to support inpatient and outpatient cancer care delivery. The code sits within the broader pharmaceutical supply chain and reflects procurement of a specialized, regulated therapeutic agent requiring compliance with FDA licensing, state pharmacy board oversight, and hospital formulary management protocols.

The source material provided contains no recent state and local contract opportunities tagged to UNSPSC 51112204, so current solicitation activity, issuing-body distribution, and geographic concentration cannot be characterized from available data.